Pan-cancer bioinformatics analysis of TIPRL in human tumors
These findings establish TIPRL as a significant biomarker in cancer progression and immune regulation, warranting further exploration into its therapeutic implications across diverse tumor types.
Authors
- Xuezhong Zhang (ORCID: https://orcid.org/0000-0002-7159-4702)
- Kaihui Sha
- Hao Xue (ORCID: https://orcid.org/0000-0001-7478-8898)
- Tonggang Liu (ORCID: https://orcid.org/0000-0003-1550-8029)
- Yuanyuan Lv (ORCID: https://orcid.org/0000-0003-4736-3733)
- Yuntao Zhou
Institutions
- Binzhou Medical University (CN)
- Shandong University of Aeronautics (CN)
- Central Hospital of Zibo (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-03-15
- DOI
- https://doi.org/10.1007/s12672-025-02070-9
- Citations
- 2
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.61